BOCA RATON, Fla., Sept. 26 /PRNewswire-FirstCall/ -- Biomedtex Inc. ("Biomed" or "the Company"), a life science development company, announced today that A. Marc Rocca, 42, will be President and CEO.
About Biomedtex Inc.
The Company's mission is to identify, evaluate and assess a broad spectrum of global medical technologies, and healthcare solutions, and then seek to capture and promote innovations with significant commercial and beneficial potential. The Company relies on comprehensive due diligence, technical and business analysis, performed by its Management, Financial, Advisory and Scientific Boards. Biomed will then acquire or form opportunity specific Subsidiaries to Commercialize and Promote the Practical use of the identified Healthcare Solutions. Biomed's Subsidiaries will be independently financed and managed after development and start-up phases while being fully supported by Biomed. Proven Subsidiaries will then be introduced to the broader financial market as stand alone Public Companies.
Safe Harbor Statement: This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in the forward-looking statements, particularly those risks and uncertainties inherent in the process of developing start-up companies. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. ProMed Alliance disclaims any intent or obligation to update those forward-looking statements, except as otherwise specifically stated.
Biomedtex Inc.CONTACT: A. Marc Rocca of Biomedtex Inc., +1-917-526-6700
